INFI Annual Operating Profit
-$44.84 M
+$239.00 K+0.53%
31 December 2022
Summary:
As of January 21, 2025, INFI annual operaing income is -$44.84 million, with the most recent change of +$239.00 thousand (+0.53%) on December 31, 2022. During the last 3 years, it has risen by +$820.00 thousand (+1.80%).INFI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Operating Profit
-$10.12 M
+$1.39 M+12.05%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly operating income is -$10.12 million, with the most recent change of +$1.39 million (+12.05%) on June 30, 2023. Over the past year, it has increased by +$1.90 million (+15.79%).INFI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI TTM Operating Profit
-$42.05 M
+$1.90 M+4.32%
30 June 2023
Summary:
As of January 21, 2025, INFI TTM operating income is -$42.05 million, with the most recent change of +$1.90 million (+4.32%) on June 30, 2023. Over the past year, it has increased by +$4.63 million (+9.92%).INFI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.5% | +15.8% | +9.9% |
| 3 y3 years | +1.8% | -13.5% | -1.2% |
| 5 y5 years | -23.1% | -41.8% | +7.9% |
INFI Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -334.3% | -109.4% | -319.7% |
Infinity Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$10.12 M(-12.1%) | -$42.05 M(-4.3%) |
| Mar 2023 | - | -$11.51 M(+20.6%) | -$43.94 M(-2.0%) |
| Dec 2022 | -$44.84 M(-0.5%) | -$9.54 M(-12.3%) | -$44.84 M(-4.2%) |
| Sept 2022 | - | -$10.88 M(-9.5%) | -$46.81 M(+0.3%) |
| June 2022 | - | -$12.02 M(-3.1%) | -$46.67 M(+1.7%) |
| Mar 2022 | - | -$12.41 M(+7.9%) | -$45.91 M(+1.8%) |
| Dec 2021 | -$45.08 M(+17.1%) | -$11.50 M(+7.0%) | -$45.08 M(+2.9%) |
| Sept 2021 | - | -$10.75 M(-4.5%) | -$43.82 M(+4.5%) |
| June 2021 | - | -$11.25 M(-2.9%) | -$41.91 M(+5.9%) |
| Mar 2021 | - | -$11.58 M(+13.2%) | -$39.58 M(+2.8%) |
| Dec 2020 | -$38.50 M(-15.7%) | -$10.23 M(+15.7%) | -$38.50 M(-3.3%) |
| Sept 2020 | - | -$8.85 M(-0.8%) | -$39.82 M(-4.2%) |
| June 2020 | - | -$8.92 M(-15.1%) | -$41.55 M(-1.9%) |
| Mar 2020 | - | -$10.50 M(-9.1%) | -$42.38 M(-7.2%) |
| Dec 2019 | -$45.66 M(+282.8%) | -$11.55 M(+9.2%) | -$45.66 M(+7.3%) |
| Sept 2019 | - | -$10.58 M(+8.6%) | -$42.56 M(+126.4%) |
| June 2019 | - | -$9.74 M(-29.3%) | -$18.80 M(+16.1%) |
| Mar 2019 | - | -$13.78 M(+63.0%) | -$16.19 M(+35.8%) |
| Dec 2018 | -$11.93 M(-67.3%) | -$8.46 M(-164.2%) | -$11.93 M(+3.8%) |
| Sept 2018 | - | $13.18 M(-284.7%) | -$11.49 M(-64.7%) |
| June 2018 | - | -$7.13 M(-25.0%) | -$32.52 M(-8.4%) |
| Mar 2018 | - | -$9.52 M(+18.7%) | -$35.49 M(-2.6%) |
| Dec 2017 | -$36.45 M(-74.5%) | -$8.02 M(+2.3%) | -$36.45 M(-29.4%) |
| Sept 2017 | - | -$7.84 M(-22.4%) | -$51.66 M(-19.0%) |
| June 2017 | - | -$10.11 M(-3.5%) | -$63.75 M(-43.5%) |
| Mar 2017 | - | -$10.48 M(-54.9%) | -$112.81 M(-21.2%) |
| Dec 2016 | -$143.11 M(+12.6%) | -$23.23 M(+16.5%) | -$143.11 M(-10.0%) |
| Sept 2016 | - | -$19.93 M(-66.3%) | -$159.04 M(+65.9%) |
| June 2016 | - | -$59.17 M(+45.1%) | -$95.84 M(+27.3%) |
| Mar 2016 | - | -$40.77 M(+4.1%) | -$75.26 M(-40.8%) |
| Dec 2015 | -$127.11 M(+1504.3%) | -$39.16 M(-190.5%) | -$127.11 M(+0.0%) |
| Sept 2015 | - | $43.26 M(-212.1%) | -$127.06 M(+102.9%) |
| June 2015 | - | -$38.59 M(-58.3%) | -$62.61 M(+5.7%) |
| Mar 2015 | - | -$92.61 M(+136.8%) | -$59.24 M(+647.7%) |
| Dec 2014 | -$7.92 M(-93.8%) | -$39.11 M(-136.3%) | -$7.92 M(+317.2%) |
| Sept 2014 | - | $107.70 M(-405.8%) | -$1.90 M(-98.7%) |
| June 2014 | - | -$35.22 M(-14.7%) | -$143.78 M(+1.7%) |
| Mar 2014 | - | -$41.30 M(+24.8%) | -$141.31 M(+10.7%) |
| Dec 2013 | -$127.68 M(+28.7%) | -$33.08 M(-3.2%) | -$127.68 M(-9.9%) |
| Sept 2013 | - | -$34.18 M(+4.3%) | -$141.72 M(+4.7%) |
| June 2013 | - | -$32.76 M(+18.4%) | -$135.33 M(+16.0%) |
| Mar 2013 | - | -$27.66 M(-41.3%) | -$116.67 M(+17.6%) |
| Dec 2012 | -$99.17 M(+157.4%) | -$47.13 M(+69.6%) | -$99.17 M(+51.0%) |
| Sept 2012 | - | -$27.79 M(+97.2%) | -$65.66 M(+32.8%) |
| June 2012 | - | -$14.09 M(+38.7%) | -$49.45 M(+5.8%) |
| Mar 2012 | - | -$10.16 M(-25.4%) | -$46.72 M(+21.3%) |
| Dec 2011 | -$38.53 M | -$13.61 M(+17.5%) | -$38.53 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$11.58 M(+1.9%) | -$38.54 M(-20.1%) |
| June 2011 | - | -$11.37 M(+477.8%) | -$48.21 M(+13.8%) |
| Mar 2011 | - | -$1.97 M(-85.6%) | -$42.38 M(-12.1%) |
| Dec 2010 | -$48.24 M(+3.6%) | -$13.63 M(-35.9%) | -$48.24 M(+16.3%) |
| Sept 2010 | - | -$21.25 M(+284.1%) | -$41.49 M(+40.5%) |
| June 2010 | - | -$5.53 M(-29.3%) | -$29.54 M(-20.7%) |
| Mar 2010 | - | -$7.83 M(+13.7%) | -$37.23 M(-20.0%) |
| Dec 2009 | -$46.55 M(-343.2%) | -$6.88 M(-25.9%) | -$46.55 M(-970.9%) |
| Sept 2009 | - | -$9.29 M(-29.7%) | $5.34 M(+228.9%) |
| June 2009 | - | -$13.23 M(-22.8%) | $1.63 M(-43.9%) |
| Mar 2009 | - | -$17.14 M(-138.1%) | $2.90 M(-84.9%) |
| Dec 2008 | $19.14 M(-182.2%) | $45.01 M(-445.9%) | $19.14 M(-154.4%) |
| Sept 2008 | - | -$13.01 M(+8.8%) | -$35.18 M(+36.8%) |
| June 2008 | - | -$11.96 M(+1226.4%) | -$25.73 M(+31.7%) |
| Mar 2008 | - | -$901.50 K(-90.3%) | -$19.54 M(-16.1%) |
| Dec 2007 | -$23.29 M(-13.0%) | -$9.31 M(+161.6%) | -$23.29 M(+31.6%) |
| Sept 2007 | - | -$3.56 M(-38.3%) | -$17.70 M(-6.2%) |
| June 2007 | - | -$5.77 M(+24.0%) | -$18.86 M(-7.9%) |
| Mar 2007 | - | -$4.65 M(+25.3%) | -$20.48 M(-23.5%) |
| Dec 2006 | -$26.76 M(-26.6%) | -$3.71 M(-21.4%) | -$26.76 M(-18.6%) |
| Sept 2006 | - | -$4.72 M(-36.1%) | -$32.87 M(-12.9%) |
| June 2006 | - | -$7.39 M(-32.4%) | -$37.73 M(+14.5%) |
| Mar 2006 | - | -$10.93 M(+11.3%) | -$32.95 M(+24.8%) |
| Dec 2005 | -$36.47 M(+8.3%) | -$9.83 M(+2.6%) | -$26.40 M(-49.1%) |
| Sept 2005 | - | -$9.58 M(+265.7%) | -$51.85 M(+23.8%) |
| June 2005 | - | -$2.62 M(-40.2%) | -$41.87 M(+8.2%) |
| Mar 2005 | - | -$4.38 M(-87.6%) | -$38.69 M(+14.9%) |
| Dec 2004 | -$33.69 M(-3095.7%) | -$35.28 M(-8891.4%) | -$33.69 M(-1340.6%) |
| Sept 2004 | - | $401.30 K(-28.5%) | $2.72 M(-1.5%) |
| June 2004 | - | $561.30 K(-11.0%) | $2.76 M(+34.5%) |
| Mar 2004 | - | $631.00 K(-43.8%) | $2.05 M(+77.8%) |
| Dec 2003 | $1.12 M(-101.7%) | $1.12 M(+152.7%) | $1.15 M(-102.0%) |
| Sept 2003 | - | $443.90 K(-402.8%) | -$58.66 M(-3.0%) |
| June 2003 | - | -$146.60 K(-44.9%) | -$60.50 M(-4.5%) |
| Mar 2003 | - | -$265.90 K(-99.5%) | -$63.34 M(-1.6%) |
| Dec 2002 | -$64.38 M(+339.6%) | -$58.69 M(+4108.1%) | -$64.38 M(+390.0%) |
| Sept 2002 | - | -$1.39 M(-53.3%) | -$13.14 M(-30.6%) |
| June 2002 | - | -$2.99 M(+128.1%) | -$18.94 M(+6.6%) |
| Mar 2002 | - | -$1.31 M(-82.4%) | -$17.77 M(-4.9%) |
| Dec 2001 | -$14.65 M(+250.2%) | -$7.45 M(+3.5%) | -$18.70 M(+44.1%) |
| Sept 2001 | - | -$7.20 M(+296.1%) | -$12.97 M(+76.3%) |
| June 2001 | - | -$1.82 M(-18.7%) | -$7.36 M(+23.1%) |
| Mar 2001 | - | -$2.23 M(+29.3%) | -$5.98 M(+43.0%) |
| Dec 2000 | -$4.18 M(+21.3%) | -$1.73 M(+9.2%) | -$4.18 M(+70.4%) |
| Sept 2000 | - | -$1.58 M(+263.7%) | -$2.45 M(+181.5%) |
| June 2000 | - | -$435.10 K(-0.4%) | -$871.80 K(+99.6%) |
| Mar 2000 | - | -$436.70 K | -$436.70 K |
| Dec 1999 | -$3.45 M | - | - |
FAQ
- What is Infinity Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual operating profit year-on-year change?
- What is Infinity Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly operating profit year-on-year change?
- What is Infinity Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals TTM operating profit year-on-year change?
What is Infinity Pharmaceuticals annual operaing income?
The current annual operating profit of INFI is -$44.84 M
What is the all time high annual operating profit for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual operaing income is $19.14 M
What is Infinity Pharmaceuticals annual operating profit year-on-year change?
Over the past year, INFI annual operaing income has changed by +$239.00 K (+0.53%)
What is Infinity Pharmaceuticals quarterly operating income?
The current quarterly operating profit of INFI is -$10.12 M
What is the all time high quarterly operating profit for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly operating income is $107.70 M
What is Infinity Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, INFI quarterly operating income has changed by +$1.90 M (+15.79%)
What is Infinity Pharmaceuticals TTM operating income?
The current TTM operating profit of INFI is -$42.05 M
What is the all time high TTM operating profit for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high TTM operating income is $19.14 M
What is Infinity Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, INFI TTM operating income has changed by +$4.63 M (+9.92%)